
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $454.4M | -- | -- | $1.31 | -- |
08/05/2025 | Q2 | $440.7M | -- | -- | $1.24 | -- |
05/08/2025 | Q1 | $467.6M | $440.8M | $1.31 | $1.42 | -$0.11 |
02/18/2025 | Q4 | $447.4M | $466.8M | -$2.82 | $1.36 | -$4.18 |
11/06/2024 | Q3 | $442.1M | $443.4M | $1.33 | $1.35 | -$0.02 |
08/06/2024 | Q2 | $468.7M | $435M | $1.24 | $1.37 | -$0.13 |
05/09/2024 | Q1 | $504M | $500.2M | $1.65 | $1.64 | $0.01 |
02/13/2024 | Q4 | $479.5M | $494.7M | $1.51 | $1.62 | -$0.11 |
11/07/2023 | Q3 | -- | -- | $1.57 | $1.45 | $0.12 |
08/08/2023 | Q2 | -- | -- | $1.16 | $1.28 | -$0.12 |
05/03/2023 | Q1 | -- | -- | $1.33 | $1.17 | $0.16 |
02/21/2023 | Q4 | -- | -- | $1.02 | $1.40 | -$0.38 |
11/08/2022 | Q3 | -- | -- | $1.55 | $1.41 | $0.14 |
08/02/2022 | Q2 | -- | -- | $1.29 | $1.36 | -$0.07 |
05/03/2022 | Q1 | -- | -- | $1.46 | $1.19 | $0.27 |
02/15/2022 | Q4 | -- | -- | $0.96 | $1.07 | -$0.11 |
11/02/2021 | Q3 | -- | -- | $0.94 | $0.96 | -$0.02 |
08/03/2021 | Q2 | -- | -- | $0.90 | $0.89 | $0.01 |
05/04/2021 | Q1 | -- | -- | $0.94 | $0.99 | -$0.05 |
02/16/2021 | Q4 | -- | -- | $0.91 | $0.77 | $0.14 |
11/03/2020 | Q3 | -- | -- | $0.51 | $0.38 | $0.13 |
08/04/2020 | Q2 | -- | -- | -$1.62 | $0.31 | -$1.93 |
05/05/2020 | Q1 | -- | -- | $1.34 | $1.23 | $0.11 |
02/18/2020 | Q4 | -- | -- | $1.26 | $1.38 | -$0.12 |
11/05/2019 | Q3 | -- | -- | $1.22 | $1.25 | -$0.03 |
08/06/2019 | Q2 | -- | -- | $0.90 | $1.10 | -$0.20 |
05/07/2019 | Q1 | -- | -- | $1.17 | $1.18 | -$0.01 |
02/19/2019 | Q4 | -- | -- | $0.83 | $1.37 | -$0.54 |
11/06/2018 | Q3 | -- | -- | $0.84 | -- | -- |
08/07/2018 | Q2 | -- | -- | $0.89 | -- | -- |
05/08/2018 | Q1 | -- | -- | $0.90 | -- | -- |
02/13/2018 | Q4 | -- | -- | -$0.20 | -- | -- |
11/07/2017 | Q3 | -- | -- | $0.95 | -- | -- |
08/08/2017 | Q2 | -- | -- | $1.06 | -- | -- |
05/09/2017 | Q1 | -- | -- | $0.70 | -- | -- |
02/14/2017 | Q4 | -- | -- | $0.90 | -- | -- |
11/02/2016 | Q3 | -- | -- | $0.47 | -- | -- |
08/02/2016 | Q2 | -- | -- | $1.18 | -- | -- |
05/04/2016 | Q1 | -- | -- | $0.77 | -- | -- |
02/17/2016 | Q4 | -- | -- | $1.28 | -- | -- |
11/04/2015 | Q3 | -- | -- | $1.45 | -- | -- |
Innospec reported $440.8M worth of top line sales in its most recent quarter.
Innospec announced earnings per share of $1.31 which represents a miss of analyst forecast a $1.42 per share.
Innospec reported $125.1M that represents $4.98 per share over the last quarter.
Innospec's earnings are forecast to grow from $1.42 per share to $5.87 per share next year representing an increase of 292.72%.
Innospec's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.